Ahmed or Baerveldt GDD implantation decreases corneal endothelial cell density by 204.7 cells/mm2 at 12 months in anterior chamber settings
This systematic review and meta-analysis assessed corneal endothelial cell density changes following Ahmed or Baerveldt glaucoma drainage device implantation in eyes without pre-existing corneal endothelial pathologies. The study included 572 eyes in an anterior chamber setting with a follow-up of 12.0 months.
The primary outcome showed that ECD decreased by 204.7 cells/mm2 with a 95% CI of 149.2 to 260.1. ECD loss at 24 months decreased by 287.8 cells/mm2 with a 95% CI of 233.0 to 342.7. Loss varied between 12 and 629.6 cells/mm2 at 12 months after sulcus or pars plana placement where p-values were not reported.
Subgroup analysis indicated ECD loss was greater in predominantly Asian populations with a mean difference of 225.5 cells/mm2 compared to predominantly Caucasian populations with a mean difference of 155.3 cells/mm2. No difference was found between Ahmed and Baerveldt GDD types regarding ECD loss.
Limitations include existing evidence heterogeneity and significant heterogeneity in studies that precluded meta-analysis of available data for sulcus or pars plana placement. The authors state that further high-quality randomized controlled trials are necessary to establish definitive estimates. Implantation of a GDD leads to clinically relevant corneal endothelial cell loss.